10.1111/j.1749-6632.1991.tb16965.x Ann N Y Acad Sci
The proactive approach to monitoring side effects contributes to improved adherence and treatment outcomes
In some areas, its clear that GLP-1s have clearly strong, positive effects on an individuals health and well-being (i.e., diabetes, obesity), and in other areas, its not yet clear, but we may soon find the same (i.e., neurological diseases)
Some patients begin noticing reduced appetite and modest weight loss within the first 46 weeks, with more visible results appearing by month two or three.
Philip Rabito, M.D., a specialist in endocrinology, weight loss and wellness in New York City, shared in a previous interview with Fox News Digital that this new class of weight-loss drugs is positioned to "approach bariatric surgery level outcomes" although it doesn't come without risks
These early benefits are primarily from the B vitamin and L-Carnitine components